An observational study on the effect of ranolazine and trimetazidine in stable angina patients in a tertiary care hospital in eastern India

摘要

Background: There have been many advances in the treatmentof coronary artery disease (CAD) during the past threedecades. Despite treatment with conventional agents and/or revascularization,many patients remain symptomatic. Availability ofnew agents, like ranolazine could be used with other antianginaltherapies without causing excessive reductions in myocardialO2 demand determinants would be of enormous value. Metabolicagent like trimetazidine improves cardiac metabolism and cardiacenergy availability in chronic stable angina.